Global High-Priority Regulatory Events — February 03, 2026

04-02-2026

Alphabet Inc. filed an 8-K on February 4, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a standard earnings-related disclosure, but no specific revenue, earnings, margins, guidance, or other financial metrics are disclosed in the provided filing details. No positive or negative performance indicators, period-over-period changes, or transaction values were mentioned.

• ·Accession Number: 0001652044-26-000012
• ·File Size: 752 KB

04-02-2026

04-02-2026

04-02-2026

Orion Group Holdings Inc filed an 8-K on February 4, 2026, reporting entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), which represents a significant corporate event. However, the filing also discloses creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03) and unregistered sales of equity securities (Item 3.02), introducing potential debt and dilution risks. Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01) are included, but no specific deal terms or financial metrics are detailed.

04-02-2026

04-02-2026

04-02-2026

04-02-2026

04-02-2026

04-02-2026

Cooper Companies, Inc. filed an 8-K on February 4, 2026, disclosing entry into a material definitive agreement under Item 1.01, with financial statements and exhibits provided under Item 9.01. No specific details on the agreement's nature, parties, dollar value, or financial impacts are disclosed. This is a multi-item filing focused on a material event, but lacks quantitative metrics or comparisons.

04-02-2026

MicroVision, Inc. filed an 8-K on 2026-02-04 (AccNo: 0001493152-26-004952, Size: 204 KB) disclosing under Item 2.01 the completion of an acquisition or disposition of assets. Item 9.01 provides for financial statements and exhibits related to the event. No specific details on transaction parties, value, structure, or impacts are disclosed.

04-02-2026

LAM Research Corp filed an 8-K on February 4, 2026 (AccNo: 0000707549-26-000014), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election or appointment of directors or certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, reason for change, timing, or any quantitative metrics are disclosed.

04-02-2026

Launch One Acquisition Corp. filed an 8-K on 2026-02-04 announcing the termination of a material definitive agreement under Item 1.02. Item 9.01 discloses financial statements and exhibits, but no specific details, metrics, or context are provided. No positive developments or offsetting information reported.

04-02-2026

Midland States Bancorp, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or financial impacts are disclosed.

04-02-2026

Inspirato Inc filed an 8-K on 2026-02-04 announcing the completion of an acquisition or disposition of assets (Item 2.01) alongside a change in control of the registrant (Item 5.01). However, the filing also discloses termination of a material definitive agreement (Item 1.02), notice of delisting or failure to satisfy a continued listing rule (Item 3.01), and material modifications to rights of security holders (Item 3.03), which may negatively impact liquidity and shareholder value. Additional disclosures include changes in directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), and Regulation FD information (Item 7.01).

04-02-2026

Valuence Merger Corp. I filed an 8-K on February 4, 2026 (AccNo: 0001493152-26-004997) under Item 8.01 Other Events announcing a Merger/Acquisition event. No specific deal structure, parties involved, valuation, financial terms, or strategic rationale are disclosed. Sector is not specified.

04-02-2026

04-02-2026

04-02-2026

04-02-2026

Lamb Weston Holdings, Inc. filed an 8-K on 2026-02-04 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, timing, or quantitative data are disclosed.

04-02-2026

Uber Technologies, Inc. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, an officer change or appointment under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and financial statements and exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, timing, or financial metrics are disclosed. The filing size is 696 KB with AccNo 0001543151-26-000011.

04-02-2026

Silicon Laboratories Inc. filed an 8-K on February 4, 2026, reporting entry into a material definitive agreement under Item 1.01 and Regulation FD disclosure under Item 7.01, with financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing for the material agreement, likely filed timely within 4 business days. Specific details on the agreement, transaction value, parties, financial impacts, or other metrics are NOT_DISCLOSED.

04-02-2026

Haymaker Acquisition Corp. 4 filed an 8-K on 2026-02-04 (AccNo: 0001104659-26-010028, Size: 274 KB) disclosing unregistered sales of equity securities under Item 3.02, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers under Item 5.02, and financial statements and exhibits under Item 9.01. No quantitative metrics, period-over-period comparisons, deal structure details, parties involved, valuation, synergies, or other transaction specifics are explicitly stated. No positive or negative performance metrics are present.

04-02-2026

Medalist Diversified REIT, Inc. filed an 8-K on February 4, 2026 (AccNo: 0001104659-26-010034), reporting entry into a material definitive agreement under Item 1.01, with exhibits attached under Item 9.01. No specific details on the agreement terms, parties, transaction value, financial impacts, or strategic rationale are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material event.

04-02-2026

FUELCELL ENERGY INC filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01 (Financial Statements and Exhibits). No specific details such as key positions affected, names of individuals, appointment or resignation status, reasons for the change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other numerical data are provided in the filing summary.

04-02-2026

Freshpet, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names, reasons for change, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

04-02-2026

Functional Brands Inc. filed a Form 8-K on February 4, 2026, under Item 3.03 disclosing material modifications to rights of security holders. Item 9.01 lists financial statements and exhibits. No specific details on the modifications, financial impacts, dollar values, or quantitative metrics were provided.

04-02-2026

Fusemachines Inc. filed an 8-K on 2026-02-04 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No details on the agreement terms, parties, financial impacts, or metrics are disclosed.

04-02-2026

UNITED RENTALS, INC. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, internal/external status, timing, or any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

04-02-2026

04-02-2026

DT Cloud Star Acquisition Corp filed an 8-K on 2026-02-04 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No merger/acquisition details, quantitative metrics, parties, valuations, or performance data were explicitly stated in the filing summary. No positive, negative, or flat metrics reported.

04-02-2026

Entera Bio Ltd. filed a Form 8-K on 2026-02-04 disclosing entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No quantitative financial metrics, transaction details, personnel names, or directional impacts (positive or negative) were specified. This is a multi-item informational filing with no disclosed period-over-period comparisons or flat performance indicators.

04-02-2026

PAVmed Inc. filed a multi-item Form 8-K on February 4, 2026, disclosing entry into a material definitive agreement (Item 1.01) and termination of another (Item 1.02), alongside creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), material modifications to security holder rights (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), and Regulation FD disclosure (Item 7.01). No quantitative details such as transaction values, share counts, or financial impacts are provided in the filing summary. These events suggest potential restructuring or financing activities, but lack of specifics limits assessment of net positive or negative implications.

04-02-2026

Sangamo Therapeutics, Inc. filed a Form 8-K on 2026-02-04 reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. The filing represents a multi-item disclosure of a potentially strategic transaction but also potential share dilution from equity sales. No specific transaction values, share counts, financial impacts, or strategic details are disclosed.

04-02-2026

Cuentas Inc. filed a multi-item Form 8-K on February 4, 2026, disclosing entry into a material definitive agreement under Item 1.01 and material modifications to rights of security holders under Item 3.03, alongside Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). The filing lacks specific details on transaction terms, financial impacts, or quantitative metrics. Modifications to shareholder rights may introduce dilution risks, while the new agreement could signal strategic opportunities.

04-02-2026

International Land Alliance Inc. filed a Form 8-K on February 4, 2026, reporting under Item 3.03 material modifications to rights of security holders, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, Item 5.07 submission of matters to a vote of security holders, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No quantitative financial metrics, transaction values, or period-over-period comparisons are disclosed. This multi-item filing provides governance and shareholder-related updates without specified positive or negative impacts.

04-02-2026

Brookfield Asset Management Ltd. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02 and departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02. Financial statements and exhibits are referenced under Item 9.01. No specific details on leadership changes, financial metrics, names, positions, reasons, or quantitative data are disclosed in the provided filing information.

04-02-2026

CECO Environmental Corp filed an 8-K on 2026-02-04 reporting entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03. Item 9.01 provides Financial Statements and Exhibits. No quantitative details, terms, positive or negative metrics, or directional impacts are disclosed.

• ·AccNo: 0001193125-26-036815
• ·File Size: 2 MB
• ·Multi-item mandatory 8-K filing

04-02-2026

Piper Sandler Companies filed an 8-K on 2026-02-04 disclosing changes related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics are disclosed.

04-02-2026

04-02-2026

04-02-2026

NRG Energy, Inc. filed an 8-K on February 4, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. No quantitative metrics, financial impacts, or performance comparisons are mentioned.

04-02-2026

Dayforce, Inc. filed an 8-K on 2026-02-04 disclosing completion of an acquisition or disposition of assets (Item 2.01) alongside entry into a new material definitive agreement (Item 1.01), but also termination of another material definitive agreement (Item 1.02), notice of delisting or failure to satisfy listing standards (Item 3.01), and changes in control of the registrant (Item 5.01). Additional disclosures include unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), changes in directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), and Regulation FD disclosure (Item 7.01). No financial terms, parties, valuations, or quantitative metrics were explicitly stated.

04-02-2026

CHOICEONE FINANCIAL SERVICES INC filed an 8-K on 2026-02-04 related to an officer change, including Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the key position affected, whether it is an appointment or resignation, reason for the change, timing, or any named executives are disclosed. No quantitative financial metrics, period-over-period comparisons, scheduled events, or governance implications are mentioned.

• ·AccNo: 0000905729-26-000032
• ·File Size: 5 MB
• ·Event Type: Officer Change
• ·Item 5.02 (typical for officer changes) not explicitly listed

04-02-2026

MSC Income Fund, Inc. filed an 8-K on February 4, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, individual names, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

• ·Filing AccNo: 0001535778-26-000016
• ·File size: 294 KB
• ·Sector: not specified

04-02-2026

VSE Corp filed an 8-K on 2026-02-04 (AccNo: 0001193125-26-036858) reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement terms, transaction value, financial impacts, or other metrics are disclosed. This is a multi-item mandatory filing with no quantitative data provided.

04-02-2026

04-02-2026

04-02-2026

i-80 Gold Corp. filed an 8-K on 2026-02-04 disclosing an officer change or departure under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or any financial metrics are disclosed in the provided filing information.

04-02-2026

WAFD INC filed an 8-K on 2026-02-04 disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). Specific details on leadership changes, such as key positions affected, appointment or resignation reasons, board meeting outcomes, or quantitative metrics, are NOT_DISCLOSED. No positive or negative performance metrics, period-over-period comparisons, or scheduled events are mentioned.

• ·AccNo: 0000936528-26-000023
• ·File Size: 209 KB
• ·Sector: NOT_DISCLOSED

04-02-2026

Maison Solutions Inc. filed an 8-K on February 04, 2026, disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. Item 9.01 provides financial statements and exhibits. No specific deal terms, parties, valuations, or financial impacts are disclosed.

04-02-2026

OKMIN RESOURCES, INC. filed a Form 8-K on 2026-02-04 disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits (AccNo: 0001079973-26-000165, Size: 677 KB). No details on the agreement, transaction value, parties, financial impacts, or metrics are provided in the filing summary. This is a multi-item mandatory disclosure of a material event.

04-02-2026

ALT5 Sigma Corp filed an 8-K on 2026-02-04 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, or any quantitative impacts were disclosed.

04-02-2026

Global AI, Inc. filed an 8-K on February 04, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.

04-02-2026

04-02-2026

Lifevantage Corp filed an 8-K on 2026-02-04 disclosing results of operations and financial condition (Item 2.02), a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), and financial statements and exhibits (Item 9.01). No specific details on the officer change, including key position, appointment or resignation status, reasons, timing, or any financial metrics are explicitly stated. No quantitative data, period-over-period comparisons, or scheduled events were disclosed.

04-02-2026

Aligos Therapeutics, Inc. filed an 8-K on 2026-02-04 (AccNo: 0001193125-26-037558, Size: 137 KB) disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, appointment or resignation status, reasons for change, timing, or any quantitative metrics are provided. This is a routine SEC-required disclosure for material leadership events with no additional context available.

• ·Filing Accession Number: 0001193125-26-037558
• ·Filing Size: 137 KB
• ·Event Date: 2026-02-04
• ·Sector: NOT_DISCLOSED

04-02-2026

Workday, Inc. filed a Form 8-K on 2026-02-04 under Item 2.02 (Results of Operations and Financial Condition), Item 2.05 (Costs Associated with Exit or Disposal Activities), and Item 2.06 (Material Impairments), indicating a multi-item disclosure. While results of operations may include performance updates, the presence of exit/disposal costs and material impairments points to negative financial pressures such as restructuring and asset write-downs. Specific metrics, dollar values, or period-over-period comparisons are NOT_DISCLOSED.

04-02-2026

PagerDuty, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. Specific details on the affected position, individual name, appointment or resignation, reasons, or timing are NOT_DISCLOSED.

04-02-2026

Eureka Acquisition Corp filed an 8-K on 2026-02-04 disclosing entry into a Material Definitive Agreement under Item 1.01, likely related to a merger or acquisition event. The filing also reports creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. No specific quantitative metrics, parties involved, deal terms, or performance comparisons are disclosed.

04-02-2026

SUNation Energy, Inc. filed an 8-K on 2026-02-04 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). Specific details on the nature of the agreement, financial obligation, transaction value, or any quantitative impacts are NOT_DISCLOSED. No revenue, earnings, balance sheet effects, guidance changes, or other metrics provided.

04-02-2026

AquaBounty Technologies Inc. filed an 8-K on 2026-02-04 disclosing Item 5.01 Changes in Control of Registrant and Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or compensatory terms are disclosed. No financial metrics, performance data, or quantitative information provided.

04-02-2026

Lipella Pharmaceuticals Inc. filed an 8-K on February 4, 2026 (AccNo: 0001753926-26-000265), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, named individuals, or any quantitative data such as compensation amounts are disclosed. Sector information is NOT_DISCLOSED.

04-02-2026

Firefly Neuroscience, Inc. filed an 8-K on 2026-02-04 disclosing entry into a material definitive agreement under Item 1.01 and departure/election of directors or certain officers, including compensatory arrangements of certain officers under Item 5.02. Item 9.01 includes financial statements and exhibits. No specific transaction details, financial metrics, or quantitative impacts are disclosed.

04-02-2026

TransMedics Group, Inc. filed an 8-K on 2026-02-04 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative impacts are disclosed. Sector information is not specified.

04-02-2026

Revolve Group, Inc. filed an 8-K on 2026-02-04 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant). Item 9.01 discloses Financial Statements and Exhibits. No transaction details, dollar values, financial metrics, or impacts are provided.

04-02-2026

Kinsale Capital Group, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 lists financial statements and exhibits. No specific details on affected positions, individuals, reasons, or impacts are disclosed.

04-02-2026

Greenbrier Companies Inc filed an 8-K on February 4, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the nature of the agreement, transaction size, parties involved, financial terms, or impacts are disclosed in the provided filing summary. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

04-02-2026

COPT DEFENSE PROPERTIES filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer, position, reason, timing, or any quantitative data are disclosed.

04-02-2026

Launchpad Cadenza Acquisition Corp I filed an 8-K on 2026-02-04 disclosing a merger/acquisition event under Item 8.01 (Other Events) and providing financial statements and exhibits under Item 9.01. No quantitative metrics, deal terms, financial impacts, positive or negative performance indicators, or period-over-period comparisons are disclosed in the provided filing summary. Critical details such as parties involved, valuation, structure, and strategic rationale remain NOT_DISCLOSED.

04-02-2026

GenFlat Holdings, Inc. filed an 8-K on February 4, 2026, disclosing under Item 1.01 entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction size, financial impacts, or other metrics are provided in the available information. This is a multi-item filing with no quantitative data or performance metrics disclosed.

04-02-2026

Krispy Kreme, Inc. filed an 8-K on 2026-02-04 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for change, timing, or implications are disclosed. This is a routine disclosure with no quantitative metrics, positive or negative changes reported.

04-02-2026

USCB Financial Holdings, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on affected positions, individuals involved, reasons for change, or quantitative data are disclosed.

04-02-2026

American Healthcare REIT, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, appointment or resignation status, reasons, or any quantitative metrics are disclosed.

• ·Filing accession number: 0001193125-26-037696
• ·Filing size: 214 KB

04-02-2026

Columbus McKinnon Corp filed an 8-K on February 4, 2026, disclosing entry into a material definitive agreement (Item 1.01), termination of a prior material definitive agreement (Item 1.02), completion of an acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), changes in directors or officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). The filing signals a merger/acquisition event but includes both positive developments like acquisition completion and potentially negative ones like agreement termination and new financial obligations. Specific details on parties, deal structure, values, and impacts are NOT_DISCLOSED.

04-02-2026

Alliance Resource Partners LP filed an 8-K on 2026-02-04 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits, likely including the agreement document. No specific details on the agreement terms, transaction value, parties, financial impacts, or metrics are disclosed.

04-02-2026

Asbury Automotive Group Inc filed an 8-K on February 04, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and Item 5.03 disclosing amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals affected, reasons for changes, financial impacts, or quantitative metrics are disclosed.

04-02-2026

Stifel Financial Corp filed an 8-K on February 4, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, financial metrics, positive or negative impacts, or period-over-period comparisons are provided.

04-02-2026

Adial Pharmaceuticals, Inc. filed an 8-K on February 4, 2026, reporting under Item 3.03 material modifications to rights of security holders, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details, transaction values, financial metrics, positive or negative changes, or period-over-period comparisons disclosed. No quantitative impacts or directional biases are evident from the available information.

04-02-2026

WRAP Technologies, Inc. filed a Form 8-K on February 4, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, dollar values, share counts, or financial impacts for these items are disclosed. This is a multi-item filing with no period-over-period comparisons or guidance provided.

04-02-2026

Middleby Corp filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, timing, or quantitative impacts are disclosed.

04-02-2026

Post Holdings, Inc. filed a Form 8-K on February 4, 2026, disclosing events under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing reports governance-related changes and outcomes from a shareholder vote, but no specific details, vote results, amendment descriptions, or financial metrics are provided in the available information. No positive or negative performance metrics are mentioned.

04-02-2026

XTI Aerospace, Inc. filed an 8-K on 2026-02-04 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), alongside changes in directors or certain officers including compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No quantitative metrics, deal values, parties involved, or performance comparisons—positive, negative, or flat—are provided in the filing summary. This informational filing signals a completed material transaction but lacks details to assess impact.

• ·AccNo: 0001213900-26-012273
• ·File size: 867 KB

04-02-2026

Maze Therapeutics, Inc. filed a Form 8-K on February 04, 2026, reporting entry into a new material definitive agreement under Item 1.01, termination of a prior material definitive agreement under Item 1.02, and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. This multi-item filing signals significant contractual changes and new obligations, but no specific details, dollar values, or strategic context were disclosed. The combination suggests potential strategic shifts offset by new financial commitments.

04-02-2026

Uniti Group Inc. filed an 8-K on February 4, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, or financial impacts are disclosed.

04-02-2026

Rubrik, Inc. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and financial statements/exhibits under Item 9.01. No specific details on the officer position affected, appointment/resignation status, reasons, timing, financial metrics, or quantitative data are disclosed. Sector is not specified.

04-02-2026

Evercore Inc. filed an 8-K on 2026-02-04 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics such as compensation amounts are disclosed. No positive or negative performance metrics, scheduled events, or financial impacts are mentioned.

04-02-2026

SiTime Corp filed a Form 8-K on February 4, 2026 (AccNo: 0001193125-26-037802, Size: 6 MB), reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing for the material agreement, with Regulation FD potentially voluntary if triggered. No specific details on the agreement terms, transaction value, financial impacts, or quantitative metrics are disclosed in the provided filing summary.

04-02-2026

CION Investment Corp filed an 8-K on February 4, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's parties, terms, value, or financial implications are provided. This is a multi-item mandatory filing with no quantitative metrics or performance comparisons disclosed.

04-02-2026

Laser Photonics Corp filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, appointment or resignation status, reasons for change, and any governance implications are NOT_DISCLOSED.

04-02-2026

Cadiz Inc filed an 8-K on 2026-02-04 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names of individuals, reasons for changes, timing, or any financial metrics are disclosed in the provided filing summary. This appears to be a routine governance disclosure with no additional quantitative or qualitative context provided.

04-02-2026

Envirotech Vehicles, Inc. filed an 8-K on February 4, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also covers Item 5.07 submission of matters to a vote of security holders and Item 9.01 financial statements and exhibits. Specific details including names, positions affected, reasons for changes, voting outcomes, or exhibit contents are NOT_DISCLOSED.

04-02-2026

Luminar Technologies, Inc./DE filed an 8-K on February 4, 2026, disclosing the termination of a material definitive agreement under Item 1.02 and the completion of an acquisition or disposition of assets under Item 2.01. Item 9.01 references financial statements and exhibits, but no specific financial metrics, parties, or terms were detailed. This filing provides informational updates on transactional events without quantified impacts.

04-02-2026

Space Asset Acquisition Corp. filed an 8-K on February 4, 2026 (AccNo: 0001213900-26-012366), disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition event. No specific deal structure, parties, valuation, financial terms, or strategic rationale were detailed in the filing summary provided. Sector details were not specified.

04-02-2026

UPEXI, INC. filed an 8-K on February 4, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement terms, transaction value, parties involved, financial impacts, or other metrics are disclosed in the provided filing summary. This represents a mandatory disclosure of a material event without quantitative data or directional implications.

04-02-2026

KRAKacquisition Corp filed an 8-K on 2026-02-04 (AccNo: 0001140361-26-003733, Size: 386 KB) disclosing Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits in connection with a labeled Merger/Acquisition event. No deal structure, parties involved, valuation, financial terms, strategic rationale, synergies, regulatory pathway, or shareholder impacts are explicitly stated or quantified in the provided filing details. Sector is not specified, with no positive or negative metrics, comparisons, or scheduled events disclosed.

• ·Critical missing information: Deal structure, parties (acquirer/target), valuation (equity/enterprise value), consideration type (cash/stock), strategic rationale, synergies, EPS impact, regulatory approvals, shareholder vote details, timeline, and sector context - all required for full M&A analysis

04-02-2026

Oracle Corp filed a Form 8-K on 2026-02-04 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details provided on the agreement, events, transaction value, financial impacts, or metrics. No quantitative data, period-over-period comparisons, or scheduled events are disclosed.

04-02-2026

Vivakor, Inc. filed an 8-K on February 4, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or financial impacts provided. No quantitative metrics, period-over-period comparisons, or guidance changes are mentioned.